Johnson & Johnson agrees to buy Alza for $10.5 billion in stock


Tuesday, March 27th 2001, 12:00 am

By: News On 6


NEW YORK (AP) _ Health care giant Johnson & Johnson said Tuesday it plans to buy drug delivery specialist Alza Corp. for $10.5 billion in stock that analysts said will make it cheaper for J&J to find the most effective ways for patients to take its drugs.

Alza, based in Mountain View, Calif., developed the technology for the best-selling Nicoderm nicotine patches sold by GlaxoSmithKline. It also makes time-released capsules that allow people to take fewer pills and systems that use electricity to push drugs through skin.

The purchase by New Brunswick, N.J.-based maker of Band-Aids and Tylenol had been rumored for weeks.

The companies said in a statement Tuesday that their boards had approved the deal and hope to complete it in the July-September quarter. It is subject to approval by Alza shareholders and by regulators in the U.S. and Europe.

logo

Get The Daily Update!

Be among the first to get breaking news, weather, and general news updates from News on 6 delivered right to your inbox!

More Like This

March 27th, 2001

April 18th, 2022

April 18th, 2022

April 18th, 2022

Top Headlines

December 6th, 2022

December 6th, 2022

December 6th, 2022

December 6th, 2022